Predictors of post-transplant survival in patients with newly diagnosed acute myeloid leukemia receiving frontline venetoclax and hypomethylating agents.
Year: 2025
Type: conference-abstract
Study design: Observational Study
Source: Journal of Clinical Oncology
Authors: Isla Johnson, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Michelle A. Elliott, Abhishek A. Mangaonkar, Aasiya Matin, Antoine N. Saliba, Mehrdad Hefazi, William J. Hogan, Mithun Vinod Shah, Mrinal Patnaik, Animesh Dev Pardanani, Mark Robert Litzow, Ayalew Tefferi, Naseema Gangat
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410807974
